Patent details

EP2889034 Title: Composition comprising ceftaroline and tobramycin

Basic Information

Publication number:
EP2889034
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP141964056
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Composition comprising ceftaroline and tobramycin
French Title of Invention:
Composition comprenant ceftaroline et tobramycine
German Title of Invention:
Zusammensetzungen enthaltend Ceftarolin und Tobramycin
SPC Number:

Dates

Filing date:
28/08/2009
Grant date:
27/02/2019
EP Publication Date:
01/07/2015
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
27/02/2019
EP B1 Publication Date:
27/02/2019
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
28/08/2019
Expiration date:
28/08/2029
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
20/02/2019
 
 

Name:
Pfizer Anti-Infectives AB
Address:
Vetenskapsvägen 10, SE-191 90 Sollentuna, Sweden (SE)

Inventor

Name:
Biek, Donald
Address:
United States (US)

Priority

Priority Number:
92497 P
Priority Date:
28/08/2008
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/546; A61P 31/04;

Publication

European Patent Bulletin

Issue number:
201909
Publication date:
27/02/2019
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages